For the last 5 years, Improved Pharma has carried out a number of Synchrotron-based studies at Argonne National Laboratory, and especially beamlines 6-ID-D and 11-BM. Beamline 11-BM is optimized for powder diffraction analysis of crystals and formulations containing crystalline materials and beamline 6-ID-D is optimized for total scattering analysis of amorphous materials and formulations. Both of these beamlines are the best in the world or among the best two or three beamlines in the world for their particular analysis. Improved Pharma has the required arrangements with the US Department of Energy to use these facilities for proprietary measurements. Additionally, Improved Pharma has the proper agreements to carry out proprietary studies at the Industrial Pharmacy Services Laboratory and at charge-back X-ray diffraction, NMR, and porcine pharmacology centers at Purdue University. The COO of Improved Pharma is responsible for all studies and has access to consultants and technicians needed to carry out all of the studies in a highly accurate, professional manner.
